日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

"Pharmacological" analysis of atrial fibrillation maintenance mechanism: reentry, wavelets, or focal?

心房颤动维持机制的“药理学”分析：折返、小波还是局灶性？

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2025.1447542
Burashnikov, Alexander
发表日期：2025
文献求助 收藏

Eye Gaze Entropy Reflects Individual Experience in the Context of Driving

眼动熵反映了驾驶情境中的个人经验

期刊:Entropy
影响因子:2
doi:10.3390/e28010008
Arutyunova, Karina; Burashnikov, Evgenii; Timakin, Nikita; Shishalov, Ivan; Filimonov, Andrei; Bakhchina, Anastasiia
发表日期：2025
文献求助 收藏

Discriminative Capabilities of Eye Gaze Measures for Cognitive Load Evaluation in a Driving Simulation Task

眼动追踪测量在驾驶模拟任务中评估认知负荷的区分能力

期刊:
影响因子:
doi:10.3390/jemr19010001
Bakhchina, Anastasiia; Arutyunova, Karina; Burashnikov, Evgenii; Filatova, Anastasiya; Filimonov, Andrei; Shishalov, Ivan
神经科学
发表日期：2025
文献求助 收藏

Effect of Flecainide and Ibutilide Alone and in Combination to Terminate and Prevent Recurrence of Atrial Fibrillation

氟卡尼和伊布利特单独及联合用药对终止和预防房颤复发的影响

期刊:Circulation-Arrhythmia and Electrophysiology
影响因子:9.8
doi:10.1161/CIRCEP.123.012454
Burashnikov, Alexander; Di Diego, José M; Patocskai, Bence; Echt, Debra S; Belardinelli, Luiz; Antzelevitch, Charles
发表日期：2024
文献求助 收藏

Advances in basic and translational research in atrial fibrillation

心房颤动基础研究和转化研究进展

期刊:Philosophical Transactions of the Royal Society B-Biological Sciences
影响因子:4.7
doi:10.1098/rstb.2022.0174
Hu, Dan; Barajas-Martinez, Hector; Zhang, Zhong-He; Duan, Hong-Yi; Zhao, Qing-Yan; Bao, Ming-Wei; Du, Yi-Mei; Burashnikov, Alexander; Monasky, Michelle M; Pappone, Carlo; Huang, Cong-Xin; Antzelevitch, Charles; Jiang, Hong
发表日期：2023
文献求助 收藏

Atrial Fibrillation Induced by Anticancer Drugs and Underling Mechanisms

抗癌药物诱发心房颤动及其潜在机制

期刊:Journal of Cardiovascular Pharmacology
影响因子:2.2
doi:10.1097/FJC.0000000000001182
Burashnikov, Alexander
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Intracellular uptake of agents that block the hERG channel can confound the assessment of QT interval prolongation and arrhythmic risk

细胞内摄取阻断hERG通道的药物可能会干扰QT间期延长和心律失常风险的评估。

期刊:Heart Rhythm
影响因子:5.7
doi:10.1016/j.hrthm.2021.08.028
Burashnikov, Alexander; Barajas-Martinez, Hector; Cox, Robert; Demitrack, Mark A; Fossler, Michael J; Kramer, Michael; Kleiman, Robert B; Kowey, Peter; Antzelevitch, Charles
ERG
细胞生物学
发表日期：2021
文献求助 收藏

Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?

抗心房颤动药物的药理学研究及其终止心律失常的机制：2020 年我们取得了哪些进展？

期刊:Journal of Cardiovascular Pharmacology
影响因子:2.2
doi:10.1097/FJC.0000000000000892
Burashnikov, Alexander
发表日期：2020
文献求助 收藏

The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.

小电导钙激活钾通道抑制剂 NS8593 和 UCL1684 通过选择性抑制心房钠通道活性来预防心房颤动的发生

期刊:Journal of Cardiovascular Pharmacology
影响因子:2.2
doi:10.1097/FJC.0000000000000855
Burashnikov Alexander, Barajas-Martinez Hector, Hu Dan, Robinson Victoria M, Grunnet Morten, Antzelevitch Charles
心血管
发表日期：2020
文献求助 收藏

Mutations in NaV1.5 Reveal Calcium-Calmodulin Regulation of Sodium Channel

NaV1.5 突变揭示钙-钙调蛋白对钠通道的调节

期刊:Frontiers in Physiology
影响因子:3.2
doi:10.3389/fphys.2019.00700
Eyal Nof, Leonid Vysochek, Eshcar Meisel, Elena Burashnikov, Charles Antzelevitch, Jerome Clatot, Roy Beinart, David Luria, Michael Glikson, Shimrit Oz
信号转导
发表日期：2019
文献求助 收藏